Patents by Inventor Joseph M. Dhahbi

Joseph M. Dhahbi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160024575
    Abstract: This application describes small noncoding RNA markers that can be found in a biological sample taken from an individual. The level of such markers are useful for determining the individual's health status, especially in comparison with others. Methods and kits for the use of these markers are provided as well.
    Type: Application
    Filed: May 2, 2014
    Publication date: January 28, 2016
    Applicant: The Regents of the University of California
    Inventors: Stephen Spindler, Joseph M. Dhahbi
  • Patent number: 8403844
    Abstract: Methods and systems for monitoring interventions and/or a subject, such as a human patient. One exemplary embodiment of a method includes measuring at least one biological parameter of a subject, determining a biological state from the measuring, administering (after the measuring) an intervention which includes a caloric restriction (CR) mimetic to the subject and measuring, after the administering, the at least one biological parameter and determining a later biological state from the measuring after the administering.
    Type: Grant
    Filed: March 16, 2006
    Date of Patent: March 26, 2013
    Assignee: BioMarker Pharmaceuticals, Inc.
    Inventors: Xi Zhao-Wilson, Paul C. Watkins, Joseph M. Dhahbi
  • Publication number: 20040002069
    Abstract: This invention is based on the discovery that certain genes have expression levels that are substantially increased or decreased in the liver of animals with diabetes. Monitoring the expression levels of such genes allows diagnosis of diabetes. In certain embodiments, the invention also provides methods of modulating the expression levels of such genes to treat diabetes and diabetic complications. In other embodiments, the invention provides a screening assay that identifies compounds which modulate the expression level of polynucleotides or functional properties of polypeptides that are over or under expressed in diabetes. In some cases, these compounds can be used to treat diabetes and diabetic complications. In still other embodiments, the invention provides assays to determine whether compounds intended for treatment of other diseases also induce diabetes.
    Type: Application
    Filed: June 21, 2002
    Publication date: January 1, 2004
    Applicant: The Regents of the University of California
    Inventors: Stephen R. Spindler, Joseph M. Dhahbi, Patricia L. Spindler
  • Patent number: RE39436
    Abstract: Long term calorie restriction has the benefit of increasing life span. Methods to screen interventions that mimic the effects of calorie restriction are disclosed. Extensive analysis of genes for which expression is statistically different between control and calorie restricted animals has demonstrated that specific genes are preferentially expressed during calorie restriction. Screening for interventions which produce the same expression profile will provide interventions that increase life span. In a further aspect, it has been discovered that test animals on a calorie restricted diet for a relatively short time have a similar gene expression profile to test animals which have been on a long term calorie restricted diet.
    Type: Grant
    Filed: March 22, 2004
    Date of Patent: December 19, 2006
    Assignee: The Regents of the University of California
    Inventors: Stephen R. Spindler, Joseph M. Dhahbi